Logo

American Heart Association

  2
  0


Final ID: MDP320

Cardiac imaging-pathology correlation in 283 pediatric heart transplant biopsy specimens: Cardiac MRI detects clinically important fibrosis

Abstract Body (Do not enter title and authors here): Background: Cardiovascular magnetic resonance (CMR) derived T1 parametric mapping offers quantitative, regional assessments of myocardial edema and fibrosis. Pediatric cardiac allografts are subject to fibrosis due to rejection inflammation, coronary vasculopathy, cardiopulmonary bypass and graft failure. The role of CMR parametric mapping in identifying clinically important myocardial fibrosis in this population remains unknown. Thus, the aim of this study was to correlate endomyocardial biopsy (EMB)-derived fibrosis measurements with local T1 values in PHTx patients.
Methods: PHTx pts undergoing EMB also underwent simultaneous cardiac MRI including T1 parametric mapping in 6 short axis slices at 1.5 T. Segmental T1 values were measured and the segments corresponding to EMB sites were noted from overlay registration. Trichrome-stained EMBs were digitally scanned and analyzed for fibrosis content. Encounters were divided into low and high fibrosis groups, and clinical variables from echocardiography, clinical treatment, and cardiac catheterization were compared using student’s t-test and linear regression.
Results: Thirty-three PHTx pts (age of 12.8 + 4.9 years) underwent 94 surveillance encounters, for a total of 283 EMB samples. 75 encounters had no active rejection and 19 encounters had active rejection requiring treatment. Average T1 was significantly higher in active rejection group (1056 vs 1018 ms, p<0.01), and there was no difference in fibrosis score between the 2 groups, thus identifying rejection as the main driver of T1 elevation. In the group with no active rejection, the T1 value from the EMB site was elevated in the high fibrosis score group (1023 vs 1011 ms, p=0.01). Of these patients without rejection, the higher fibrosis group had higher BNP (626 vs 145, p=0.04), higher lateral mitral E/e’ (8 vs 6.6, p=0.03) and higher RVEDP (11 vs 9 mmHg, p=0.05), all suggestive of more significant diastolic dysfunction.
Conclusions: CMR derived segmental T1 value can detect clinically significant graft rejection. In the absence of rejection, elevated T1 correlates with clinically significant fibrosis on EMB, which correlates with markers of diastolic dysfunction.
  • Gupta, Aditi  ( UPMC Childrens Hospital Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Cross, Russell  ( Nemours Childrens Hospital, Delaware , Rehoboth Beach , Delaware , United States )
  • Olivieri, Laura  ( UPMC Childrens Hospital Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Ceneri, Nicolle  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Mouzakis, Nick  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Richmann, Devika  ( Weill Cornell University , New York , New York , United States )
  • Kanter, Joshua  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Downing, Tacy  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Vegulla, Ravi  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Rossi, Christopher  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Berger, John  ( Children's National Hospital , Washington , District of Columbia , United States )
  • Author Disclosures:
    Aditi Gupta: DO NOT have relevant financial relationships | Russell Cross: DO NOT have relevant financial relationships | Laura Olivieri: DO NOT have relevant financial relationships | nicolle ceneri: No Answer | Nick Mouzakis: DO NOT have relevant financial relationships | Devika Richmann: DO NOT have relevant financial relationships | Joshua Kanter: No Answer | Tacy Downing: No Answer | Ravi Vegulla: DO NOT have relevant financial relationships | Christopher Rossi: No Answer | John Berger: DO have relevant financial relationships ; Research Funding (PI or named investigator):Merck Sharp and Dohme:Active (exists now) ; Research Funding (PI or named investigator):Actelion:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pediatric Transplant and Heart Failure

Saturday, 11/16/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
4-Hydroxy-2-Nonenal Alters Alternative Polyadenylation to Regulate mRNA Isoform Diversity in the Transition from Human Cardiac Fibroblasts to Myofibroblasts

Natarajan Kartiga, Neupane Rahul, Yalamanchili Hari Krishna, Palaniyandi Suresh, Wagner Eric, Guha Ashrith, Amirthalingam Thandavarayan Rajarajan

A Report of 2000 Consecutive Patients Undergoing Imaging with Pacemakers and ICDs in the MRI Environment; the Additive Value of a Large, Prospective ~20-Year Observational Study

Biederman Robert, Shah Moneal, Boltralik Mark, Williams Ronald, Lombardi Richard, Mangini Francesco, Doyle Mark

More abstracts from these authors:
CMR can discriminate need for biopsy and rejection therapy in children post heart transplant

Vegulla Ravi, Staffa Steven, Zurakowski David, Cross Russell, Olivieri Laura, Ceneri Nicolle, Richmann Devika, Mouzakis Nicholas, Hamman Karin, Kanter Joshua, Berger John, Downing Tacy, Loke Yue-hin

Shape Variations in Right Ventricular 3D Geometry are associated with adverse outcomes in Hypoplastic Left Heart Syndrome Patients: A Fontan Outcomes Registry using CMR Examination (FORCE) Study

Loke Yue-hin, Balaras Elias, D'udekem Yves, Alsaied Tarek, Olivieri Laura, Truong Uyen, Capuano Francesco, O'hara Ryan, Contento Jacqueline, Marella Nicole, Anantuni Lekha, Gaviria Susana, Kollar Sarah, Vegulla Ravi, Mehta Rittal

You have to be authorized to contact abstract author. Please, Login
Not Available